Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-29

FDA Approved: MICROGESTIN 24 FE — Supplemental Application (Mayne Pharma Inc.)

View source ↗

Summary

FDA approved a supplemental application for Microgestin 24 FE (norethindrone acetate/ethinyl estradiol and ferrous fumarate) by Mayne Pharma Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MICROGESTIN 24 FE (NORETHINDRONE ACETATE/ETHINYL ESTRADIOL AND FERROUS FUMARATE)

Snippet

SUPPL AP for MICROGESTIN 24 FE (NORETHINDRONE ACETATE/ETHINYL ESTRADIOL AND FERROUS FUMARATE)